News on G C Laboratories Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated G C Laboratories Ltd news from BioPortfolio.com Tue, 09 Feb 2010 23:40:28 GMT en Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas:http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033618&HITNO=0&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033618&THISHREF=http://c.moreover.com/click/here.pl%3fz2535294980%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033618&HITNO=0&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033618&THISHREF=http://c.moreover.com/click/here.pl%3fz2535294980%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033636&HITNO=1&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033636&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033636&HITNO=1&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033636&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033623&HITNO=2&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033623&THISHREF=http://c.moreover.com/click/here.pl%3fz2535296597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033623&HITNO=2&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033623&THISHREF=http://c.moreover.com/click/here.pl%3fz2535296597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Research and Markets: Incredible Anaerobes: From Physiology to Genomics to Fuelshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028142&HITNO=3&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028142&THISHREF=http://c.moreover.com/click/here.pl%3fz2532595416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028142&HITNO=3&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028142&THISHREF=http://c.moreover.com/click/here.pl%3fz2532595416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in uterohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031862&HITNO=4&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031862&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031862&HITNO=4&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031862&THISHREF=http://c.moreover.com/click/here.pl%3fz2534400328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Sunridge International extends distribution contract with Beijing Vision World Tradinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024630&HITNO=5&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024630&THISHREF=http://c.moreover.com/click/here.pl%3fz2529011442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024630&HITNO=5&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024630&THISHREF=http://c.moreover.com/click/here.pl%3fz2529011442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Functional Hip Characteristics of Baseball Pitchers and Position Playershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024606&HITNO=6&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024606&THISHREF=http://c.moreover.com/click/here.pl%3fz2529007337%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024606&HITNO=6&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024606&THISHREF=http://c.moreover.com/click/here.pl%3fz2529007337%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Journal of Sports Medicine: Effect of Graft Selection on the Incidence of Postoperative Infection in Anterior Cruciate Ligament Reconstruchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024622&HITNO=7&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024622&THISHREF=http://c.moreover.com/click/here.pl%3fz2529009091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024622&HITNO=7&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024622&THISHREF=http://c.moreover.com/click/here.pl%3fz2529009091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Journal of Sports Medicine: Chinese Distribution Contract Extended for an Additional 4 Yearshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022505&HITNO=8&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022505&THISHREF=http://c.moreover.com/click/here.pl%3fz2527703803%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022505&HITNO=8&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022505&THISHREF=http://c.moreover.com/click/here.pl%3fz2527703803%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011182&HITNO=9&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011182&THISHREF=http://c.moreover.com/click/here.pl%3fz2522788126%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011182&HITNO=9&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011182&THISHREF=http://c.moreover.com/click/here.pl%3fz2522788126%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Teva Announces FDA Accepts BLA For XM02http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010905&HITNO=10&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010905&THISHREF=http://c.moreover.com/click/here.pl%3fz2522666824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010905&HITNO=10&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010905&THISHREF=http://c.moreover.com/click/here.pl%3fz2522666824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Teva Announces FDA Accepts BLA for XM02http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010173&HITNO=11&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010173&THISHREF=http://c.moreover.com/click/here.pl%3fz2522278020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010173&HITNO=11&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010173&THISHREF=http://c.moreover.com/click/here.pl%3fz2522278020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Teva announces FDA accepts BLA for Neupogen biosimilarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017256&HITNO=12&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017256&THISHREF=http://c.moreover.com/click/here.pl%3fz2525061447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017256&HITNO=12&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017256&THISHREF=http://c.moreover.com/click/here.pl%3fz2525061447%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHemOnc Town: Updates for Teva (Nasdaq:TEVA), Trimeris (Nasdaq:TRMS), U.S. Physical Therapy (NASDAQ:USPH)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011396&HITNO=13&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011396&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011396&HITNO=13&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011396&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916140%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Updates for Teva (Nasdaq:TEVA), Trimeris (Nasdaq:TRMS), U.S. Physical Therapy (NASDAQ:USPH)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011268&HITNO=14&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011268&THISHREF=http://c.moreover.com/click/here.pl%3fz2522860435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011268&HITNO=14&MSIZE=162&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=G%20C%20Laboratories%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011268&THISHREF=http://c.moreover.com/click/here.pl%3fz2522860435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: